Full Press Release Details
Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH.
SGMT
Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH
Key Takeaway: Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH